Press Releases

26 September 2017 – ACG Associated Capsules site in Pithampur, India receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the ACG Associated Capsules’ site in Pithampur, India has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the ACG Associated Capsules Pithampur site in India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of hard gelatin capsule shells IP, hard gelatin capsule shells and empty hydroxyl propyl methyl cellulose capsule shells.

Read more

19 September 2017 – Peter Greven site in The Netherlands, receives EXCiPACT GMP/GDP certification

EXCiPACT asbl is delighted to announce that the Peter Greven site in Venlo has recently been awarded an EXCiPACT Certificate from DQS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Peter Greven site in Venlo, The Netherlands, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) and GDP Certification Standard (GDP).  Its scope covers manufacturing and distribution of LIGAMED® magnesium and calcium stearate grades for use as pharmaceutical excipients.

Read more

24 August 2017 – Hangzhou Rossen Lipids Technology site in China receives EXCiPACT GMP certification as pharmaceutical excipients suppliers

EXCiPACT asbl is delighted to announce that the Hangzhou Rossen Lipids Technology site in Zhejiang Province has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Hangzhou Rossen Lipids Technology Co., Ltd. site in Hangzhou, Zhejiang province, in China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of anhydrous lanolin, lanolin oil and lanolin wax used as pharmaceutical excipients.

Read more

17 August 2017 – Colorcon’s Indianapolis site receives EXCiPACT GMP certification as pharmaceutical excipients suppliers

EXCiPACT asbl is delighted to announce that the Colorcon Inc., Indianapolis site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Colorcon Inc., site in Indianapolis, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of tablet disintegrant aid, filler and binder based on maize starch, and enteric coating for modified or extended release or taste masking, for use as pharmaceutical excipients.

Read more

20 July 2017 – Caravan Ingredients Company Missouri site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Caravan Ingredients Company site in Missouri, USA has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Caravan Ingredients Company Grandview site in Grandview, Missouri, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers processing of fully hydrogenated refined vegetable oil into dry fine powder for use as a pharmaceutical excipient.

Read more

13 July 2017 – ACG Associated Capsules Private Limited site in Khandala (India) receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the ACG Associated Capsules Private Limited site in Khandala (India) has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the ACG Associated Capsules Private Limited site in Khandala in Maharashtra, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of hard gelatin capsule shells IP and hard gelatin capsule shells.

Read more

4 July 2017 – SEPPIC Shanghai Chemical Specialities Co. Ltd site in China receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the SEPPIC Shanghai Chemical Specialities Co. Ltd site in China has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the SEPPIC Shanghai Chemical Specialities Co. Ltd site in China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing of veterinary vaccine adjuvants for use as pharmaceutical excipients: Montanide™ products range.

Read more

13 June 2017 – NK Ingredients Pte Ltd Singapore site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the NK Ingredients Pte Ltd Singapore site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the NK Ingredients Pte Ltd site in Singapore manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of lanolin, lanolin derivatives and cholesterol for pharmaceutical use.

Read more

08 June 2017 – Star-Tech & JRS Specialty Products Co., Ltd Chinese site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Star-Tech & JRS Specialty Products Co., Ltd Chinese site has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Star-Tech & JRS Specialty Products Co., Ltd site in Changsou District, Chongqing, China manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of Povidone, Crospovidone and Copovidone.

Read more

06 June 2017 – Asha Cellulose (I) Pvt. Ltd. site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Asha Cellulose (I) Pvt. Ltd. site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Asha Cellulose (I) Pvt. Ltd. site in Valsad, Gujarat, India manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture and supply of ethylcellulose and aqueous dispersion of ethylcellulose for use as pharmaceutical excipients.

Read more

30 May 2017 – Ashland Speciality Ingredients Belgium site receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Ashland Speciality Ingredients site in Doel, Belgium has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Speciality Ingredients (ASI) site in Doel, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production of methylcellulose (MC), hydroxypropylmethylcellulose (HPMC) and methylhydroxyethylcellulose (MHEC) as pharmaceutical excipients.

Read more

23 May 2017 – Sigachi Industries Pvt. Ltd. Indian site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Sigachi Industries Pvt. Ltd.’s site in Dahej, India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Sigachi Industries Pvt. Ltd.’s site in Dahej, District Bharuch, Gujarat in India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers Manufacture and supply of cellulose based pharmaceutical excipients in the pharmaceutical industry.

Read more

16 May 2017 – Shanxi Guangsheng Medicinal Capsule Co., Ltd site receives EXCiPACT GMP Certification

EXCiPACT asbl is delighted to announce that the Shanxi Guangsheng Medicinal Capsule Co., Ltd’s Shanxi Province site has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Shanxi Guangsheng Medicinal Capsule Co., Ltd site in Jinzhong City, Shanxi Province, China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of Gelatin, Pullulan and HPMC printed and unprinted empty capsule for pharmaceutical use.

Read more

06 April 2017 – Croda Japan’s Shiga factory receives EXCiPACT GMP certification

EXCiPACT asbl is pleased to announce their very first Japanese certification.

The Croda Japan K.K. Shiga factory has just been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Croda Japan Shiga factory in Shiga-Ken, Japan manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of pharmaceutical excipients, (functional ester derivative, purified mineral oil, vegetable oil, wax, fatty acid and lanolin).

Read more

04 April 2017 – Both Croda Inc. manufacturing sites in the USA receive GMP certification

EXCiPACT asbl is delighted to announce that both Croda Inc. manufacturing sites in the USA have recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificates demonstrates that the Croda Inc. sites in Mill Hall, Pennsylvania and in New Castle, Delaware manufacture pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  The scope covers the manufacturing of alkyloxylates, esters and super refined oils and PEGs at Mill Hall and the manufacturing of alkyloxylates and esters at New Castle.

Read more

23 March 2017 – Chemische Fabrik Budenheim KG site in Budenheim receives EXCiPACT GMP/GDP certification

EXCiPACT asbl is delighted to announce that the Chemische Fabrik Budenheim KG site in Budenheim has recently been awarded an EXCiPACT GMP/GDP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Chemische Fabrik Budenheim KG site in Budenheim, Germany, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards.  Its scope covers manufacturing, testing, storage and distribution of sodium, magnesium and calcium phosphates for use as pharmaceutical excipients.

Read more

21 March 2017 – Sudeep Pharma’s Indian site in Switzerland receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Sudeep Pharma Private Ltd’s Vadodara site in India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Sudeep Pharma Pvt. Ltd. site in Vadodara, Gujarat, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers manufacture of different grades of Di basic calcium phosphate, Tri basic calcium phosphate and calcium carbonate for use as pharmaceutical excipients.

Read More

14 March 2017 – Carbagas Domdidier site in Switzerland receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Carbagas Domdidier site has recently been awarded an EXCiPACT Certificate from AJA, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Carbagas site in Domdidier, Switzerland, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing (filling) of pharmaceutical grade gases (nitrogen, oxygen, argon, carbon dioxide) in cylinders and bundles.

Read more

2017 EXCiPACT STANDARDS REVISION – STAKEHOLDER CONSULTATION OPENS

The EXCiPACT Board commissioned a project team to undertake a revision of the EXCiPACT standards to align them to ISO 9001:2015 and ISO/IEC 17021-1:2015 without change or enhancement of any individual requirements, other than to correct for errors in the original publication. The draft revision has been completed and is now available for public comment via a Review Template, mandatory for the submission of comments. Links to both documents are:

Read more

28 February 2017 – Chemfield Cellulose’ Indian Site receives EXCiPACT GMP certification

The Certificate demonstrates that the Chemfield Cellulose Private Ltd site in Nagpur, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture and supply of different grades of Microcrystalline cellulose for use as excipients in pharmaceuticals.

Read more

21 February 2017 – Anhui Sunhere Pharmaceutical Excipients Chinese site receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that Anhui Sunhere Pharmaceutical Excipients Co. Ltd in Huainan, China has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Anhui Sunhere Pharmaceutical Excipients Co. Ltd site in Huainan, Anhere, China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the manufacture of magnesium stearate, microcrystalline cellulose and low-substituted hydroxypropyl cellulose.

Read more

09 February 2017 – Ashland Specialties France site in Alizay receives EXCiPACT certficate

EXCiPACT asbl is delighted to announce that Ashland Specialties France has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Specialties France site in Alizay, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers manufacture of Carmellose Sodium / Sodium Carboxymethylcellulose in bags for use as excipient in the pharmaceutical industry.

Read more

07 February 2017 – KLK Emmerich site in Düsseldorf receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that KLK Emmerich GmbH has recently been awarded an EXCiPACT Certificate from DQS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that KLK Emmerich GmbH’s site in Düsseldorf, Germany, manufactures and distributes pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standards. Its scope covers the manufacturing and distribution of Glycerine Edenor® G86 PH and  Edenor®
G 99,8 PH including filling of tank trucks, drums, IBC, storage and dispatch. of pharmaceutical excipients.

Read more

10 January 2017 – VWR’S Ohio sites receive EXCiPACT GMP & GDP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that two VWR sites in Ohio, USA have each recently been awarded an EXCiPACT GMP & GDP Certificate from blue inspection body (bmb), one of EXCIPACT’s internationally-recognised Certification Bodies.

Separate bmb certificates demonstrate that the AMRESCO, LLC site in Solon, OH and the VWR Chemicals, LLC site in Aurora, OH – both owned by VWR International, LLC of Radnor, PA – operate their facilities according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standards. The scope at both sites covers sourcing, testing, packaging, storage, release and distribution of products for pharmaceutical excipient use; salts, carbohydrates, denaturants and buffers.

Read more

25 October 2016 – Ashland Industries Nederland’s Zwijndrecht site receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that Ashland Industries Nederland’s Zwijndrecht site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Ashland Industries Nederland’s Zwijndrecht site in The Netherlands, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers the manufacturing of Hydroxy Ethyl Cellulose (Natrosol Pharm type) as a pharmaceutical excipient.

Read more

6 September 2016 – Air Liquide Benelux Industries Charleroi site receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that Air Liquide Benelux Industries’ Marchienne-au-Pont Charleroi site has recently been awarded an EXCiPACT GMP Certificate from DQS GmbH, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Air Liquide Benelux Industries site in Marchienne-au-Pont, Charleroi, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production, purification, storage, loading and distribution of liquid nitrogen and liquid oxygen under the brand name Phargalis.

Read more